This research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a novel treatment that utilizes - …

GBMGlioma Glioblastoma MultiformeTumor, Brain

~Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT05086497

Phase 1

A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP l…

Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more

~Estimated

~$10 – $8,750

Tango Therapeutics, Inc.NCT06810544